While Fukuyahma and his colleagues found a way to detect allergies from low
levels of chemicals using elevated lymphocytes and surface antigen
expression of B cells as biomarkers for what they claim is multiple chemical
sensitivity (MCS), much is left unproven.
These studies do not address whether people who are experiencing the toxic
effects of chemicals, as opposed to allergy, would also experience elevated
lymphocytes and B cell antigens. The typical MCS incitants were not
studied.
